Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.

Launched by OBELAB, INC. · Feb 6, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how much oxygen is reaching different areas of the brain in patients who have had an acute ischemic stroke, which happens when blood flow to the brain is blocked. Researchers will use a special device called near-infrared spectroscopy to measure oxygen levels in both the damaged area of the brain and a healthy area. The goal is to understand the differences in oxygen levels, which may help improve treatment for stroke patients in the future.

To participate, you need to be an adult over 19 years old and have been diagnosed with an acute ischemic stroke within the last week. You'll also need to have brain imaging done, like a CT scan or MRI, to confirm your stroke and its effects. If you choose to take part, you’ll be closely monitored, and your participation will help researchers gather valuable information. It’s important to know that certain conditions, like having jaundice or problems with your skull, might prevent you from joining the study. Overall, this trial is a chance to contribute to important research that could benefit future stroke patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults over age 19
• • Patients diagnosed with acute ischemic stroke within 7 days of symptom onset
• • Patient's condition confirmed to have an acute ischemic stroke and also brain blood vessels condition confirmed through brain imaging such as Brain CT/CTA/CT perfusion and Brain MRI/MRA
• • Patients voluntarily agree to participate and scheduled to participate in this clinical trial
• • Patients willing to comply with the clinical trial protocol
• Exclusion Criteria:
• • Patients without brain imaging result
• • Patients diagnosed with jaundice (hyperbilirubinemia) with abnormal skin color - Patients who find it difficult to wear medical devices for clinical trial on their foreheads
• • Patients who has skull fractures of external shape not maintained normal
• • Patients who does not agree to participate in this clinical trial
• • Patients who are currently participating in another clinical trial or have participated in another clinical trial within 30 days of the screening date
• • Patients who is determined from investigator that participating is inappropriate because it may affect the results of the clinical trial or ethically